National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 4)1
National Health Act 1953
I, FELICITY McNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Determination under section 85B of the National Health Act 1953.
Dated 10 June 2011
FELICITY McNEILL
Acting First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
1 Name of Instrument
(1) This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 4).
(2) This Instrument may also be cited as PB 43 of 2011.
2 Commencement
This Instrument commences on 1 July 2011.
3 Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1 Amendments
[1] Schedule 1, entry for Bleomycin
omit:
|
| Injection | Blenamax | 10 | 439.63 | 835.12 |
[2] Schedule 1, entry for Dothiepin
omit:
| Tablet containing dothiepin hydrochloride 75mg | Oral | Prothiaden | 30 | 2.10 | 2.76 |
[3] Schedule 1, omit entry for Prazosin
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.